trial · primary record
AB-1015
Carcinoma, Ovarian Epithelial
| Phase | Phase 1 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | 19 |
| Primary completion | 2026-10-26 |
| Primary endpoint | Incidence of adverse events and dose limiting toxicities (DLTs) |
| Registry ID | NCT05617755 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:33:06.222Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05617755
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.